Neuroinflammation is a key pathological feature of numerous neurological disorders and is commonly associated with activation of microglia in the central nervous system. The 18 kDa translocator protein (TSPO) is highly upregulated in activated microglia and has therefore become an established biomarker for imaging neuroinflammatory processes using positron emission tomography (PET). Among second-generation TSPO radiotracers, […]
Author Archives: truemeds
Zasocitinib is an emerging selective Janus kinase (JAK) pathway inhibitor under clinical investigation for the treatment of immune-mediated inflammatory diseases. By targeting intracellular signaling within the JAK-STAT pathway, it aims to reduce pathological cytokine activity associated with conditions such as psoriasis, rheumatoid arthritis, and other autoimmune disorders. Its selective mechanism is designed to maintain therapeutic […]
Natural product–derived insecticides continue to play a critical role in modern agriculture as the demand for effective, sustainable, and environmentally responsible pest control solutions increases. Spinetoram represents a successful example of how microbial natural products can be transformed into next-generation agrochemicals through the integration of biosynthetic knowledge, computational modeling, and synthetic chemistry. Building on the […]
REV-ERBα and REV-ERBβ are ligand-dependent nuclear receptors that function as transcriptional repressors at the core of circadian, metabolic, and inflammatory regulatory networks. While heme has been established as the endogenous agonist of REV-ERB, its porphyrin scaffold and broad biological reactivity limit its suitability for selective pharmacological modulation. Recent advances in structural biology have clarified how […]
Honokiol, a bioactive compound extracted from Magnolia species, has gained attention for its diverse health benefits. Research highlights its neuroprotective, anti-anxiety, anti-inflammatory, anticancer, and cardiometabolic effects, making it a versatile natural supplement. Honokiol’s lipophilic properties allow it to cross the blood-brain barrier, enhancing its impact on cognitive function and stress reduction. It modulates key cellular […]
Oligopeptide-50 is a bioactive cosmetic peptide widely incorporated into modern skincare formulations targeting hyperpigmentation and early signs of aging. As a short-chain amino acid sequence, it functions as a signaling molecule that may help regulate melanogenesis and support collagen-related pathways. By contributing to balanced melanin production, Oligopeptide-50 is commonly used in brightening products designed to […]
Gedatolisib is an investigational dual PI3K/mTOR inhibitor designed to target a central oncogenic signaling pathway frequently dysregulated in cancer. By inhibiting all class I PI3K isoforms and both mTOR complexes, Gedatolisib provides vertical pathway blockade intended to overcome compensatory feedback mechanisms associated with single-target inhibitors. Clinical development has primarily focused on hormone receptor–positive, HER2-negative advanced […]
Icaritin is a naturally occurring prenylated flavonoid derived from Epimedium species, primarily produced via hydrolysis of icariin. It exhibits diverse pharmacological activities, including modulation of JAK/STAT3 and PI3K/AKT signaling pathways, anti-proliferative effects in hepatocellular carcinoma, immunomodulation, and potential roles in bone metabolism and anti-inflammatory responses. With higher bioavailability than its precursor icariin, icaritin has attracted […]
CagriSema is an emerging combination therapy that integrates Cagrilintide and Semaglutide to target both obesity and type 2 diabetes. By reducing appetite through MC4R receptor activation and improving glycemic control via GLP-1 receptor agonism, CagriSema provides a dual-action approach. Clinical studies indicate enhanced weight loss, better blood sugar regulation, and potential cardiovascular benefits compared to […]
Microtubule-targeting agents (MTAs) remain a cornerstone of modern cancer therapy, with decades of clinical success in treating both solid tumors and hematological malignancies. These agents exert their anticancer effects by disrupting the dynamic behavior of microtubules, essential cytoskeletal structures that regulate mitosis, intracellular transport, and cellular architecture. Recent advances in structural biology have revealed seven […]